Assistant Director, Genetic and Metabolic Disease Program
University of Texas Southwestern Medical Center
Location: Dallas, Texas
Type: Full Time
Academic / Research
Academic Medical Group
Internal Number: 1
We seek an experienced genetic counselor to help lead the Genetic and Metabolic Disease Program (GMDP) in the Children's Research Institute at the University of Texas Southwestern Medical Center in Dallas. The GMDP integrates clinical care through the Division of Pediatric Genetics and Metabolism with cutting-edge research. The clinical Division and GMDP are directed by Dr. Ralph DeBerardinis, a pediatric geneticist and world-renowned researcher in metabolic diseases. The Assistant Director will:
Serve as a liaison to link communications among the GMDP Director, local and international collaborating clinicians and the GMDP research team.
Develop and maintain partnerships with a team of medical geneticists and genetic counselors at Children’s Health – Dallas and UT Southwestern Medical Center.
Oversee a clinical protocol that performs research-based metabolomic and genomic analyses in patients/families with monogenic disorders of many kinds.
Assist in preparing case studies for presentation and publication.
Provide direct counseling support to patients and families being evaluated in the Pediatric Genetics and Metabolism clinics at UT Southwestern and Children’s Health.
Coordinate sample handling and storage.
Master's degree from board accredited program in genetics, and certification or eligible for certification as Genetic Counselor by American Board of Medical Genetics or American Board of Genetic Counseling. At least five years of clinical practice is preferred.
About University of Texas Southwestern Medical Center
The Children's Research Institute (CRI) is a collaborative venture between the University of Texas Southwestern Medical Center (UTSW) and Children's Health, a non-profit pediatric hospital in Dallas, TX. CRI hosts the Genetic and Metabolic Disease Program, a bedside-to-bench environment dedicated to discovering new treatments for rare genetic diseases, particularly those affecting children.